KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) Calculator
Calculate exact syringe units for the KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV) pre-mixed blend. The dose shown is from the combined vial. No separate math needed.
Calculate your dose
Adjust vial, water and dose. The answer updates live.
All three take the same units for the same dose. A smaller barrel just spreads it over more space.
on a U-100 syringe for a 2,000 mcg = 2 mg dose
Check that your syringe says U-100.
Assumes the pre-blended 80 mg vial, 5:1:1:1 GHK-Cu : BPC-157 : TB-500 : KPV.
Add 3 mL BAC water to your 80 mg vial. Draw to 7.5 units on a U-100 syringe for a 2 mg dose. This vial will last 40 doses.
A reminder for 2 mg (7.5 units) every day, with a free account.
Dose math and a schedule you can keep.
Syringe units in one tap. A free account adds dose reminders and calendar sync, plus alerts on the peptides you save.
Track every dose with reminders and a calendar.
- Dose remindersPush or calendar alarm
- Peptide alertsFor peptides you save
- Calendar syncApple, Google, Outlook
- Supply countsDoses left per vial
Your plans, logs and saved peptides sync to every device.
Opens a preview of your schedule first.Opens the builder with this mix. Save it to your protocols.
Your logs and saved lists are never sold, and not shared except where you choose.
Dose math and a schedule you can keep.
A reminder before each dose, calendar sync and doses left per vial, with a free account.
Opens a preview of your schedule first.Opens the builder with this mix. Save it to your protocols.
What's in This Blend
About This Blend
Does stacking four preclinical peptides in one vial actually make sense? The KLOW Blend (also called the KLOW Protocol) puts GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) together in a fixed 5:1:1:1 ratio. It evolved from the three-peptide GLOW stack. The addition of KPV brought anti-inflammatory gut protection into the mix.
Each component works through a separate mechanism. GHK-Cu is a copper-binding tripeptide first isolated by Loren Pickart in 1973. His group's analysis of public gene data from human cell lines found it shifts the activity of at least 4,000 genes (PMID 26236730). In skin cell cultures it increased collagen and elastin production (PMID 29986520). BPC-157 is a 15-amino-acid gastric juice fragment. Predrag Sikiric's group in Zagreb appears on 175 of its 233 PubMed records (October 2026), including a rat study of faster intestinal anastomosis healing (PMID 17713731). A Taiwanese lab tied its tendon effect to FAK-paxillin signaling in rat tendon fibroblasts (PMID 21030672). TB-500, a synthetic fragment of thymosin beta-4, promotes actin polymerization and cell migration. Goldstein's original work showed it increased keratinocyte migration 2- to 3-fold at concentrations as low as 10pg (PMID 10469335). KPV enters intestinal epithelial cells via the PepT1 transporter and suppresses NF-kB inflammatory signaling at nanomolar concentrations (Dalmasso et al., PMID 18061177).
The typical community protocol runs 2000mcg total blend per day for 10 weeks, followed by 4 weeks off. Most of the interest comes from the GLP-1 companion use case. Users on semaglutide or tirzepatide report that KLOW reduces nausea and supports skin tightening during rapid weight loss. That framing is entirely anecdotal. No clinical endpoint data supports it.
The FDA classified BPC-157 and GHK-Cu as Category 2 bulk drug substances in 2023-2024, restricting compounding pharmacy access. Both BPC-157 and TB-500 are WADA-prohibited. Research-grade prices run $65 to $380 per vial, with most landing near $100 to $135.
One page: what is in the vial, the dose each tier delivers per component, syringe units, cycling, and where every number comes from.
Frequently Asked Questions
Not medical advice. Talk to your provider before using any peptide. Full disclaimer